Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Waldenstrom Macroglobulinemia × Ifosfamide × 90 days × Clear all

Sponsor

Conditions

Sarcoma 5 Sarcoma, Ewing 4 Osteosarcoma 3 Lymphoma, Large B-Cell, Diffuse 3 Sarcoma, Clear Cell 2 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neurofibrosarcoma 2 Nerve Sheath Neoplasms 2 Lymphoma 2 Liposarcoma 2 Histiocytoma, Angiomatoid Fibrous 2 Granuloma, Plasma Cell 2 Fibrosarcoma 2 Dermatofibrosarcoma 2 Chondrosarcoma, Extraskeletal Myxoid 2 Wilms Tumor 1 Vascular Neoplasms 1 Teratoma 1 Solitary Fibrous Tumors 1 Smooth Muscle Tumor 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pleuropulmonary blastoma 1 Perivascular Epithelioid Cell Neoplasms 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasms, Adipose Tissue 1 Neoplasm Metastasis 1

Interventions

zanubrutinib 7 Rituximab 7 ibrutinib 4 venetoclax 3 ixazomib 3 pirtobrutinib 2 Specimen Handling 2 Prednisone 2 Magnetic Resonance Spectroscopy 2 Cyclophosphamide 2 CT-P10 2 Bortezomib 2 Biopsy 2 talquetamab 1 fludarabine 1 brexucabtagene autoleucel 1 acalabrutinib 1 Vincristine 1 Valganciclovir 1 Valacyclovir 1 Therapeutics 1 Thalidomide 1 Sirolimus 1 Polymerase Chain Reaction 1 Pharmacogenomic Variants 1 Lenalidomide 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡